PR Newswire
15 Jun 2022, 18:30 GMT+10
The company obtained a European Access Permit for in-vitro diagnostics devices (IVDD) authorized by the Netherlands CIBG of Ministry of Health, Welfare and Sport.
GUANGZHOU, China, June 15, 2022 /PRNewswire/ -- PulmoSeekTM Lung Cancer Early Detection Assay, the non-invasive blood-based cfDNA methylation detection product developed by AnchorDx for the early diagnosis of lung cancer, recently completed the procedure for EU IVDD CE Marking, and obtained IVD reagents licensing signed and issued by the CIBG of Ministry of Health, Welfare and Sport in the Netherlands. The license number is NL-CA002-2022-71591.
PulmoSeekTM is applicable for the benign and malignant diagnosis of people with 5-30mm pulmonary nodules. In the earlier stage of prospective clinical studies at 14 centers, the product's excellent performance was well verified in the following:
According to GLOBOCAN 2020 data released by the International Agency for Research on Cancer (IARC), lung cancer is the leading cause of cancer deaths (18%) with more than 2.2 million new cases and 1.8 million deaths annually worldwide. As a screening technology for lung cancer, LDCT has been widely recognized by domestic and international clinical guidelines, but the precise management of patients with pulmonary nodules after LDCT screening has also become an urgent clinical problem to be solved.
PulmoSeekTM Lung Cancer Early Detection Assay can achieve early diagnosis and treatment of lung cancer through accurate diagnosis of patients with benign and malignant pulmonary nodules. Currently, several of AnchorDx's products have obtained relevant IVD-related qualifications from US FDA and European Medicines Agency (EMA). PulmoSeek's access permit for the EU market will further promote this innovative precision medical product to benefit more patients with pulmonary nodules around the world forthwith.
About AnchorDx
AnchorDx is a world-leading developer of cancer screening and early detection solutions based on methylation NGS technology. AnchorDx strives to revolutionize single/multi/pan-cancer early screening, detection technologies, and products. The current product pipeline encompasses more than 70% of all cancers.
CONTACT : [email protected]
SOURCE Guangzhou AnchorDx Co., LTD
Get a daily dose of Sydney Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Sydney Sun.
More InformationWASHINGTON, D.C.: President Donald Trump has reversed a Biden-era executive order requiring businesses with federal contracts to pay...
FRANKFURT, Germany: UBS CEO Sergio Ermotti will receive a pay package of just over 15 million Swiss francs (US$17 million) for 2024,...
PARIS, France: French Prime Minister Francois Bayrou acknowledged over the weekend that the European Union may have miscalculated by...
NEW YORK, New York - Sellers took charge again on Wall Street Tuesday as the brief rebound that took place on Monday petered out. Stocks...
WASHINGTON, D.C.: The Trump administration has approved a plan to expand a coal mine in Montana and keep it running for 16 more years,...
ST. PETERSBURG, Florida: The Tampa Bay Rays have decided not to move forward with a $1.3 billion plan to build a new stadium next to...
WASHINGTON, D.C.: The U.S. government has placed more than 1,300 Voice of America (VOA) employees on leave and slashed funding for...
WASHINGTON, D.C./SEATTLE: Boeing is facing mounting scrutiny after a series of safety lapses and manufacturing issues, with U.S. Transportation...
OMAHA, Nebraska: Vaccines could help stop bird flu and prevent the mass killing of chickens, which has driven egg prices up to nearly...
In spectacular fashion, Israel has upended peace talks and brought to a dramatic end the ceasefire that had paused 15-months of carnage...
WASHINGTON, D.C.: The U.S. Department of Education is investigating 45 universities for possible violations of civil rights laws. ...
WASHINGTON, D.C.: Gold prices have shattered the US$3,000 per ounce barrier for the first time, driven by escalating geopolitical tensions...